Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2010
05/05/2010CN1679689B Heat-clearing and toxicity-relieving Chinese medicine preparation and production thereof
05/05/2010CN1678277B Methods and compositions for treatment of dermal conditions
05/05/2010CN1416341B Stable emulsion compositions
05/05/2010CN101701245A Method for separating SARS coronavirus main proteinase inhibitor from traditional Chinese medicine
05/05/2010CN101701218A Immune regulatory oligodeoxynucleotide for inhibiting differentiation of Th1 and Th17 and application thereof
05/05/2010CN101700401A Polyalkylene glycol with moiety for conjugating biologicallyactive compound
05/05/2010CN101700386A Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof
05/05/2010CN101700381A Pill for healing hepatitis B and softening liver
05/05/2010CN101700376A Traditional Chinese medicine for treating virus B hepatitis
05/05/2010CN101700371A Traditional Chinese medicine for treating bacillary dysentery
05/05/2010CN101700342A Pharmaceutical composition for treating hepatitis B and preparation method thereof
05/05/2010CN101700326A Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria
05/05/2010CN101700321A Chinese herbal composition for curing HIV and preparation method thereof
05/05/2010CN101700301A Traditional Chinese medicine composition for treating blue ear diseases and preparation method thereof
05/05/2010CN101700293A Traditional Chinese medicine for curing capillary bronchitis
05/05/2010CN101700292A Traditional Chinese medicine composite for curing lymphatic tuberculosis
05/05/2010CN101700290A Pharmaceutical composition for preventing and treating warm-heat diseases of livestock and poultry and preparation method thereof
05/05/2010CN101700285A Application of rumex japonicus in preparing medicines
05/05/2010CN101700284A Polygala japonica fermenting oral liquid with anti-bacterial and anti-inflammatory activity and preparation method thereof
05/05/2010CN101700283A Drug for curing chronic hepatitis B
05/05/2010CN101700281A Preparation method of mixture medicine of honeysuckle, forsythia and scutellaria baicalensis
05/05/2010CN101700278A Composition for treating liver injury
05/05/2010CN101700258A Drug for curing herpes zoster
05/05/2010CN101700257A Pomegranate peel polyphenol antibiosis and antiphlogosis effervescent tablet as well as preparation method and application thereof
05/05/2010CN101700250A medicine for treating herpes zoster
05/05/2010CN101700243A Novel medicine carrying woundplast with treating function
05/05/2010CN101700239A Combined capsule filled with glycyrrhizin solid preparation and glycine solid preparation
05/05/2010CN101700234A Flucloxacillin sodium suspension and new application thereof
05/05/2010CN101700232A Cefprozil submicron emulsion solid preparation and new application thereof
05/05/2010CN101700223A Erythromycin cydocarbonate injection and preparation process thereof
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709535 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709503 2-chloro-6-(4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}piperidin-1-yl)-N-methoxypyrimidine-4-carboxamide; 1-[4-(aminocarbonyl)-6-chloro-2-pyridinyl]4-piperidinyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate;
05/04/2010US7709500 Chemical compounds
05/04/2010US7709491 {8-Fluoro-2-(4'-fluoro-1,1'-biphenyl-4-yl)-3-[3-trifluoromethyl)phenyl]-3,4-dihydro-4-quinazolinyl}acetic acid; have high antiviral activity
05/04/2010US7709488 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
05/04/2010US7709449 Treating hepatitis infections, particularly hepatitis B viral infections; modified oligonucleotides
05/04/2010US7709444 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
05/04/2010US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells
05/04/2010US7709231 Genes encoding a nystatin polyketide synthase and their manipulation and utility
05/04/2010US7709217 Mixture comprising hemopoietic cytokine specific immunnoglobulin for use in detection of infection and immunololgical disorders
05/04/2010US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders
05/04/2010US7709211 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
05/04/2010US7709027 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene
05/04/2010US7709026 Synergistic mixture reducing pH, adjustment oxygen concentration containing peroxy compound and bioadhesive
05/04/2010US7709022 Sustained-release preparations of quinolone antibiotics and method for preparation thereof
05/04/2010US7709020 Implantable device comprising phosphorus-containing macrolides
05/04/2010US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes
05/04/2010US7709007 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
05/04/2010US7709006 Hepatitis-C virus testing
05/04/2010US7709004 Method of producing an HIV-1 immune response
05/04/2010US7709003 Method of producing an HIV-1 immune response
05/04/2010US7708988 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium
05/04/2010US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents
05/04/2010US7707970 immunogens
05/04/2010CA2463896C Injectable compositions for the controlled delivery of pharmacologically active compound
05/04/2010CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators
05/04/2010CA2439001C Water-soluble triazole antifungal agents
05/04/2010CA2437767C Heterocyclic inhibitors of erk2 and uses thereof
05/04/2010CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/04/2010CA2320467C Cycloalkene derivatives, their production and use
05/04/2010CA2319057C Compositions comprising a poly(oxyethylene)-poly(oxypropylene) block copolymer and their use
05/04/2010CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation
05/04/2010CA2223503C Transferrin receptor genes
05/04/2010CA2158134C Supplemented tissue sealant
05/04/2010CA2089376C Sugar modified oligonucleotides that detect and modulate gene expression
04/2010
04/29/2010WO2010048593A1 Compositions comprising 4- (2- ( 5-br0m0-4- ( l-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triazol-3-ylthio) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof
04/29/2010WO2010048590A1 Methods and compositions for prevention or treatment of rsv infection using modified duplex rna molecules
04/29/2010WO2010048059A1 Fosfomycin/tobramycin combinations for the treatment and prevention of ophthalmic, otological and dermatological infections
04/29/2010WO2010047737A2 Antimicrobial indoline compounds for treatment of bacterial infections
04/29/2010WO2010047295A1 Medicine for preventing or treating pain related to herpes zoster
04/29/2010WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010047120A1 PYRIDINE DERIVATIVE HAVING SUBSTITUTED HETERO RING AND SUBSTITUTED γ-GLUTAMYLAMINO GROUP, AND ANTI-FUNGAL AGENT COMPRISING SAME
04/29/2010WO2010047108A1 Calicivirus inactivation method
04/29/2010WO2010046931A2 Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof
04/29/2010WO2010046912A2 Thiophene containing analogues of fluconazole as antifungal agents and process thereof
04/29/2010WO2010046791A1 Phosphodiestarase inhibitors
04/29/2010WO2010046572A2 Anti-influenza device and composition containing extracts from olive tree leaves, grapefruit pips, rosemary, green tea and curcumin
04/29/2010WO2010046540A1 Nucleic acid binding peptide
04/29/2010WO2010046462A1 Antibiotic synergism
04/29/2010WO2010046461A2 Treatment of intracellular bacterial infections
04/29/2010WO2010046401A1 Methods of using mevalonate decarboxylase (mvd) antagonists
04/29/2010WO2010046388A1 Substituted (aza) -1-methyl-1h-quinolin-2-ones as antibacterials
04/29/2010WO2010046039A1 Mycobacterium tuberculosis vaccine
04/29/2010WO2010045987A1 Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials
04/29/2010WO2010045881A1 A vaccine composition against foot-and-mouth disease and the preparation method thereof
04/29/2010WO2010018474A3 Novel glucopyranose derivatives, preparation thereof, and biological uses thereof
04/29/2010WO2010017317A3 Use of mtor inhibitors to enhance t cell immune responses
04/29/2010WO2010011609A3 Controlled release antimicrobial compositions and methods for the treatment of otic disorders
04/29/2010WO2010009014A3 Antibiotic drug
04/29/2010WO2009143483A3 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION
04/29/2010WO2008092928A9 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF
04/29/2010US20100105946 Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105784 Pharmaceutical Pellets Comprising Modified Starch and Therapeutic Applications Therefor
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 1798